ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 45 filers reported holding ACORDA THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,862,000 | +0.8% | 8,000,000 | 0.0% | 0.05% | -5.6% |
| Q1 2017 | $6,808,000 | +19923.5% | 8,000,000 | +17677.8% | 0.05% | – |
| Q4 2016 | $34,000 | -99.5% | 45,000 | -99.5% | 0.00% | -100.0% |
| Q3 2016 | $6,946,000 | -6.4% | 8,436,000 | 0.0% | 0.05% | -3.8% |
| Q2 2016 | $7,418,000 | -55.2% | 8,436,000 | -54.4% | 0.05% | -52.7% |
| Q1 2016 | $16,557,000 | -60.8% | 18,506,000 | -49.2% | 0.11% | -59.0% |
| Q4 2015 | $42,250,000 | +21.7% | 36,450,000 | -4.1% | 0.27% | +12.1% |
| Q3 2015 | $34,711,000 | -9.4% | 38,013,000 | +0.4% | 0.24% | +0.8% |
| Q2 2015 | $38,293,000 | +4.4% | 37,870,000 | +5.3% | 0.24% | +3.0% |
| Q1 2015 | $36,692,000 | +29.3% | 35,956,000 | +46.0% | 0.23% | +22.3% |
| Q4 2014 | $28,371,000 | +39.9% | 24,621,000 | +25.6% | 0.19% | +39.3% |
| Q3 2014 | $20,273,000 | – | 19,596,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 4,000,000 | $4,603,000 | 2.85% |
| LINDEN ADVISORS LP | 9,910,000 | $11,427,000 | 2.16% |
| Context Capital Management, LLC | 1,500,000 | $1,725,000 | 2.14% |
| Mohican Financial Management, LLC | 3,500,000 | $4,027,000 | 1.98% |
| Sage Capital Management, LLC | 1,570,000 | $1,801,000 | 1.94% |
| SYMPHONY ASSET MANAGEMENT LLC | 12,771,000 | $14,695,000 | 1.83% |
| GRACE BROTHERS MANAGEMENT LLC | 1,500,000 | $1,727,000 | 1.66% |
| Fore Research & Management, LP | 24,095,000 | $27,844,000 | 1.51% |
| Wellesley Asset Management | 16,163 | $18,690,000 | 1.10% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,500,000 | $6,332,000 | 1.01% |